AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2015
Feb 18, 2015
30016_dirs_2015-02-18_f87e4b0c-ba00-4faa-bc61-9e3f60e70892.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-02-14
Reporting Person: Studer Jacqueline (CVP, Gen. Counsel & Secretary)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-14 | Non-Qualified Stock Option (right to buy) | $159.08 | A | 7165 | Acquired | 2025-02-13 | Common Stock (7165) | Direct |
| 2015-02-14 | Incentive Stock Option (right to buy) | $159.08 | A | 3140 | Acquired | 2025-02-13 | Common Stock (3140) | Direct |
| 2015-02-14 | Restricted Stock Unit | $ | A | 864 | Acquired | Common Stock (864) | Direct |
Footnotes
F1: Grant of option to buy shares of common stock that vests in five equal annual installments, beginning on the first anniversary date (02/14/2016) of the date of grant.
F2: Grant of option to buy shares of common stock that vests in five equal annual installments, beginning on the first anniversary date (02/14/2016) of the date of grant.
F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2016) of the date of grant.